LR Health & Beauty Gains Major Investment from Evoco Through Quadriga Capital

LR Health & Beauty SE, a leading entity in Europe's digital social selling market for health and beauty products, receives a significant investment from private equity firm Evoco, facilitated by shareholder Quadriga Capital. This move provides additional financial backing for the company to enhance its strategic initiatives. The partnership underscores the investors' confidence in LR Health & Beauty's business model and growth strategy.

In a related financial development, LR Health & Beauty SE has successfully issued a New Bond 2024/2028, valued at EUR 130 million, which was placed with institutional investors across Germany and Europe. The settlement of this New Bond has been finalized, earmarking approximately EUR 125 million for the early refinancing of a legacy bond. CEO Dr Andreas Laabs expressed optimism about the company's direction and the enhanced capability to implement its strategic vision, thanks to the new investments and digital advancements like the LR neo platform.